Document Classification

Section Type: RESULTS

Text: Rates of composite ischaemia were much the same in those who received bivalirudin alone and those who received heparin plus glycoprotein IIb/IIIa inhibitors (230 [9 %] patients vs 210 [8 %] patients, p = 0. 45) ; however, there were significantly fewer individuals who experienced major bleeding among those who received bivalirudin alone than among those who received heparin plus glycoprotein IIb/IIIa inhibitors (92 [4 %] patients vs 174 [7 %] patients, p < 0. 0001, relative risk 0. 52, 95 % CI 0. 40-0. 66), resulting in a trend towards better 30-day net clinical outcomes (303 [12 %] patients vs 341 [13 %] patients, p = 0. 057 ; 0. 87, 0. 75-1. 00).